The popularity of Sildenafil initially fueled a boom for the drug industry, but recent shifts present a uncertain outlook for investors. Lower-cost competitors are reducing earnings, and ongoing legal battles add more https://zubairhzyg690113.timeblog.net/77064897/sildenafil-and-big-pharma-a-risky-bet